146 related articles for article (PubMed ID: 34564896)
1. Baseline lncRNA PCAT1 high expression and its longitude increment during induction therapy predict worse prognosis in multiple myeloma patients.
Zhao P; Zhao X
J Clin Lab Anal; 2021 Nov; 35(11):e23924. PubMed ID: 34564896
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA T-cell factor 7 in multiple myeloma: A potential biomarker for deteriorated clinical features and poor prognosis.
Zhang C; Chu M; Fan Y; Wu L; Li Z; Ma X; Zhuang W
J Clin Lab Anal; 2020 Sep; 34(9):e23400. PubMed ID: 32578294
[TBL] [Abstract][Full Text] [Related]
3. Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients.
Zhou F; Guo L
Hematology; 2022 Dec; 27(1):596-602. PubMed ID: 35617291
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
Yu H; Peng S; Chen X; Han S; Luo J
J Clin Lab Anal; 2020 Sep; 34(9):e23399. PubMed ID: 32608537
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
Gao W
Scand J Clin Lab Invest; 2021 May; 81(3):194-200. PubMed ID: 33600264
[TBL] [Abstract][Full Text] [Related]
6. PHD finger protein 19 expression in multiple myeloma: Association with clinical features, induction therapy outcome, disease progression, and survival.
Li Y; Gong J; Zhang L
J Clin Lab Anal; 2021 Sep; 35(9):e23910. PubMed ID: 34390275
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
Yin Y; Yang W; Zhang L; Liu K; Luo Z
Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
[TBL] [Abstract][Full Text] [Related]
8. Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum.
Shen X; Zhang Y; Wu X; Guo Y; Shi W; Qi J; Cong H; Wang X; Wu X; Ju S
Cancer Biomark; 2017; 18(3):257-263. PubMed ID: 28085010
[TBL] [Abstract][Full Text] [Related]
9. The correlation of long non-coding RNA intersectin 1-2 with disease risk, disease severity, inflammation, and prognosis of acute ischemic stroke.
Zhang Y; Niu C
J Clin Lab Anal; 2020 Feb; 34(2):e23053. PubMed ID: 31647141
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of PCAT1, PCAT2, and PCAT5 lncRNAs and their value as diagnostic biomarkers in patients with gastric cancer.
Akhgari H; Shokri N; Dehghanzadeh P; Tayefeh-Gholami S; Rajabi A; Safaralizadeh R
Pathol Res Pract; 2023 Aug; 248():154654. PubMed ID: 37392552
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the plasma level of long non-coding RNA PCAT1 in prostatic hyperplasia and newly diagnosed prostate cancer patients.
Rezatabar S; Moudi E; Sadeghi F; Khafri S; Kopi TA; Parsian H
J Gene Med; 2020 Oct; 22(10):e3239. PubMed ID: 32529802
[TBL] [Abstract][Full Text] [Related]
12. Correlation of A-Kinase Interacting Protein 1 With Clinical Features, Treatment Response, and Survival Profiles in Patients With Multiple Myeloma.
Wang W; Xie Y; Han X; Liu Y; Li P
Technol Cancer Res Treat; 2020; 19():1533033820935856. PubMed ID: 32799782
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients.
Bao Y; Wei M; Ji X
J Clin Lab Anal; 2020 May; 34(5):e23168. PubMed ID: 31908003
[TBL] [Abstract][Full Text] [Related]
14. Natural history of multiple myeloma with de novo del(17p).
Lakshman A; Painuly U; Rajkumar SV; Ketterling RP; Kapoor P; Greipp PT; Gertz MA; Buadi FK; Lacy MQ; Dingli D; Dispenzieri A; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Hwa YL; Leung N; Go RS; Lin Y; Kourelis TV; Warsame R; Lust JA; Russell SJ; Zeldenrust SR; Kyle RA; Kumar SK
Blood Cancer J; 2019 Mar; 9(3):32. PubMed ID: 30846679
[TBL] [Abstract][Full Text] [Related]
15. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
Cho SF; Chang YC; Chang CS; Lin SF; Liu YC; Hsiao HH; Chang JG; Liu TC
BMC Cancer; 2014 Nov; 14():809. PubMed ID: 25369863
[TBL] [Abstract][Full Text] [Related]
16. Retraction: The
Zeng P; Chai Y; You C; Yue L; Wu C; Chen H; Li L; Li J; Liu H; Zhang Y; Cao T; Li Y; Hu W
Turk J Haematol; 2022 Aug; 39(3):188-195. PubMed ID: 35657175
[TBL] [Abstract][Full Text] [Related]
17. SNP rs710886 A>G in long noncoding RNA PCAT1 is associated with the risk of endometriosis by modulating expression of multiple stemness-related genes via microRNA-145 signaling pathway.
Wang L; Xing Q; Feng T; He M; Yu W; Chen H
J Cell Biochem; 2020 Feb; 121(2):1703-1715. PubMed ID: 31595574
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of Relationship between Long Non-Coding RNA Small Nucleolar RNA Host Gene 1 and Acute Myeloid Leukemia Risk and Prognosis in Pediatric Patients].
Su W; Hong Y; Jiang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1127-1136. PubMed ID: 32798387
[TBL] [Abstract][Full Text] [Related]
19. Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma.
Li X; Yang Y; Yi X
Technol Cancer Res Treat; 2020; 19():1533033820936770. PubMed ID: 32799769
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
